MUC-2-KLH conjugate vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MUC-2-KLH conjugate vaccine, covering 2012-01-31 to 2012-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21 [Phase 1]